Spanish Cooperative Group for Gastrointestinal Tumour Therapy Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2002
NCT00202774
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)

Active Ingredients

Drugs in Phase 3 Trials (3)

capecitabine (xeloda) (2 trials)

fluorouracil (efudex) (2 trials)

oxaliplatin (eloxatin) (3 trials)

Drugs in Phase 2 Trials (2)

cetuximab (erbitux) (1 trial)

leucovorin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5